Literature DB >> 10644656

Oxidant stress in hyperlipidemia-induced renal damage.

H Scheuer1, W Gwinner, J Hohbach, E F Gröne, R P Brandes, E Malle, C J Olbricht, A K Walli, H J Gröne.   

Abstract

Hyperlipoproteinemia can aggravate glomerulosclerosis and chronic tubulointerstitial (ti) damage in kidneys without primary immunologic disease. We evaluated whether the effect of hyperlipidemia on progression of renal damage differed between kidneys without preexisting glomerular disease and kidneys with mesangioproliferative glomerulonephritis and whether the renal actions of hyperlipidemia were dependent on oxidant-antioxidant balance. Hyperlipidemia was induced by high-fat and high-cholesterol diet in uninephrectomized rats. In rats without glomerulonephritis, hyperlipidemia led to a rise in glomerular and ti generation of reactive oxygen species (ROS). Oxygen radicals were mainly generated by enhanced xanthine oxidoreductase (XO), which rose with protein concentration and activity during hyperlipidemia; concurrently, glomerulosclerosis and chronic ti injury were noticed during hyperlipidemia [ti damage (% of total tubulointerstitium (TI) after 150 days): normolipidemia 0.1 +/- 0% vs. hyperlipidemia 3.4 +/- 0. 9%; P < 0.05]. In mesangioproliferative Thy-1 nephritis, ti injury was significantly accelerated by hyperlipidemia (ti damage after 150 days: normolipidemic Thy-1 nephritis 2.5 +/- 0.6% vs. hyperlipidemic Thy-1 nephritis 12.5 +/- 3.1%; P < 0.05). Antioxidant enzyme activities decreased and XO activity rose markedly in the TI (XO activity in TI after 150 days: normolipidemic Thy-1 nephritis 2.2 +/- 0.5 vs. hyperlipidemic Thy-1 nephritis 4.5 +/- 0.7 cpm/microg protein; P < 0.05). In hyperlipidemic Thy-1 nephritis rats, which had a higher urinary protein excretion than normolipidemic rats, hypochlorite-modified proteins, an indirect measure for enhanced myeloperoxidase activity, were detected in renal tissue and in urine, respectively. During hyperlipidemia, chronic damage increased in renal TI. Enhanced generation of ROS, rise in oxidant enzyme activity, and generation of hypochlorite-modified proteins in renal tissue and urine were noticed. These data suggest that oxidant stress contributed to the deleterious effects of hyperlipidemia on the renal TI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644656     DOI: 10.1152/ajprenal.2000.278.1.F63

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  33 in total

Review 1.  Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-06-22       Impact factor: 2.801

2.  The effects of combined treatment with niacin and chromium on the renal tissues of hyperlipidemic rats.

Authors:  Meliha Sengezer Inceli; Sehnaz Bolkent; M Mutluhan Doger; Refiye Yanardag
Journal:  Mol Cell Biochem       Date:  2006-11-24       Impact factor: 3.396

3.  Vitamin E and regression of hypercholesterolemia-induced oxidative stress in kidney.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2013-09-21       Impact factor: 3.396

Review 4.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

5.  Effect of Costus igneus stem extract on calcium oxalate urolithiasis in albino rats.

Authors:  K Manjula; K Rajendran; T Eevera; S Kumaran
Journal:  Urol Res       Date:  2012-10

6.  The p53-mediated apoptosis in hypercholesterolemia-induced renal injury of rats.

Authors:  Ying Yao; Xingkui Tian; Xiaocheng Liu; Jufang Shao; Yongman Lv
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

7.  Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage.

Authors:  V Sudhahar; S Ashok Kumar; P Varalakshmi; V Sujatha
Journal:  Mol Cell Biochem       Date:  2008-06-19       Impact factor: 3.396

8.  Role of LOX-1 and ROS in oxidized low-density lipoprotein induced epithelial-mesenchymal transition of NRK52E.

Authors:  Rui Wang; Guohua Ding; Wei Liang; Cheng Chen; Hongxia Yang
Journal:  Lipids Health Dis       Date:  2010-10-19       Impact factor: 3.876

9.  Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.

Authors:  Sumita Mishra; Djahida Bedja; Christine Amuzie; Alberto Avolio; Subroto Chatterjee
Journal:  Biochem Biophys Res Commun       Date:  2015-08-04       Impact factor: 3.575

Review 10.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.